CoChat

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Treatment of vascular risk factors is associated with slower decline in Alzheimer disease

Deschaintre, Yan, Richard, Florence, Leys, Didier, Pasquier, Florence · 2009 · Neurology

Abstract

BACKGROUND: There is growing evidence that vascular risk factors (VRF) contribute to cognitive decline. Whether their treatment can slow down the progression of Alzheimer disease (AD) remains unsettled. The aim of this observational study was to evaluate whether the treatment of VRF is associated with a slower cognitive decline in patients who have AD without cerebrovascular disease (CVD). METHODS: We recruited 301 consecutive patients who had AD without CVD (mean age 71.7 years; 69.4% women; first Mini-Mental State Examination [MMSE] mean score 21.6; mean follow-up 2.3 years), who had attended a memory clinic between 1997 and 2003. VRF sought were high blood pressure, dyslipidemia, diabetes mellitus, tobacco smoking, and atherosclerotic disease. Only 21 patients (7.0%) had no VRF. Others were classified as having no VRF treated (n = 72; 25.7%), some VRF treated (n = 119; 42.5%), or all VRF treated (n = 89; 31.8%). We compared MMSE progression over time among these 3 groups using a mixed random effects regression model. RESULTS: Baseline MMSE scores were similar in the 3 groups. With adjustment for confounding factors, MMSE progression over time differed significantly between groups (p = 0.002). Patients with all their VRF treated declined less than those with none of their VRF treated. Those with some VRF treated tended to have an intermediate decline. CONCLUSIONS: In patients who have Alzheimer disease without CVD, treatment of vascular risk factors (VRF) is associated with a slower decline in Mini-Mental State Examination score. Randomized controlled trials are needed to confirm this association, but our data suggest that dementia should not prevent treatment of VRF.

Overview

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e3181b59bf3

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 38 references

Cited by

See all 237

Metadata

Authors
Deschaintre, Y., Richard, F., Leys, D., & Pasquier, F.
Affiliations
Inserm (FR)
Venue
Neurology
Published
2009-09
Volume
73
Issue
9
Pages
674-680
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W1986968958
Cited by
232
References
38
Citations by year
2026: 2 · 2025: 5 · 2024: 8 · 2023: 10 · 2022: 6 · 2021: 11 · 2020: 11 · 2019: 17 · 2018: 8 · 2017: 14 · 2016: 16 · 2015: 17 · 2014: 18 · 2013: 16 · 2012: 22
FWCI
15.00
Type
journal article
Language
en
Open access
closed
Locations
  • Neurology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
Alzheimer's disease, vascular risk factors, cognitive decline, dyslipidemia, diabetes mellitus, smoking, atherosclerosis, cerebrovascular disease, Mini-Mental State Examination, dementia prevention, secondary prevention
MeSH terms
Aged, Alzheimer Disease, Hypolipidemic Agents, Cerebral Arteries, Intracranial Arteriosclerosis, Cerebrovascular Disorders, Female, Humans, Longitudinal Studies, Male, Neuropsychological Tests, Risk Factors, Risk Management, Time, Time Factors, Disease Progression, Risk Reduction Behavior

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of vascular risk factors is associated with slower decline in Alzheimer disease. https://app.cochat.ai/papers/10.1212/wnl.0b013e3181b59bf3
The paper
Deschaintre, Y., Richard, F., Leys, D., & Pasquier, F. (2009). Treatment of vascular risk factors is associated with slower decline in Alzheimer disease. Neurology. https://doi.org/10.1212/wnl.0b013e3181b59bf3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.